SRI-37330
CAS No. 2322245-42-9
SRI-37330 ( —— )
Catalog No. M28482 CAS No. 2322245-42-9
SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 110 | Get Quote |
|
10MG | 178 | Get Quote |
|
25MG | 410 | Get Quote |
|
50MG | 605 | Get Quote |
|
100MG | 860 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSRI-37330
-
NoteResearch use only, not for human use.
-
Brief DescriptionSRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
-
DescriptionSRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2322245-42-9
-
Formula Weight388.4
-
Molecular FormulaC16H19F3N4O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Protionamide
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
-
Tigloylgomisin P
Tigloylgomisin P shows moderate to marginal cytotoxicity against A549, PC-3, KB and KBvin human cancer cell lines.
-
Plantamajoside
Plantamajoside has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.